Grove Bank & Trust’s Acadia Pharmaceuticals ACAD Stock Holding History

Grove Bank & Trust’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.06K	Hold	200	–	–	﹤0.01%	722
2026 Q1	$4.45K	Hold	200	–	–	﹤0.01%	718
2025 Q4	$5.34K	Hold	200	–	–	﹤0.01%	713
2025 Q3	$4.27K	Hold	200	–	–	﹤0.01%	727
2025 Q2	$4.31K	Hold	200	–	–	﹤0.01%	713
2025 Q1	$3.32K	Hold	200	–	–	﹤0.01%	724
2024 Q4	$3.67K	Hold	200	–	–	﹤0.01%	628
2024 Q3	$3.08K	Hold	200	–	–	﹤0.01%	614
2024 Q2	$3.25K	Hold	200	–	–	﹤0.01%	532
2024 Q1	$3.7K	Hold	200	–	–	﹤0.01%	542
2023 Q4	$6.26K	Hold	200	–	–	﹤0.01%	517
2023 Q3	$4.17K	Hold	200	–	–	﹤0.01%	589
2023 Q2	$4.79K	Hold	200	–	–	﹤0.01%	549
2023 Q1	$3.76K	Hold	200	–	–	﹤0.01%	590
2022 Q4	$3K	Buy	+200	New	+$3.13K	﹤0.01%	554

Other funds holding ACAD

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return